Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays

Proteomics

Volumn 11, Issue 8, 2011, Pages 1499-1507

  Hu, Shen ^a,b   Vissink, Arjan ^c   Arellano, Martha ^a   Roozendaal, Caroline ^c   Zhou, Hui ^a   Kallenberg, Cees G M ^c   Wong, David T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Autoantibody biomarker; Protein arrays; Protein microarray; Sj gren's syndrome

Indexed keywords

AUTOANTIBODY; BIOLOGICAL MARKER; HISTONE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MICROARRAY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTONES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; PROTEIN ARRAY ANALYSIS; SALIVA; SJOGREN-LARSSON SYNDROME; TRANSGLUTAMINASES;

EID: 79953722819     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000206     Document Type: Article

References (31)

1. Fox, R., Sjogren's syndrome. Lancet 2005, 366, 321-331.
2. Hansen, A., Lipsky, P. E., Dorner, T., B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat. Clin. Pract. Rheum. 2007, 3, 561-569.
3. Vitali, C., Bombardieri, S., Jonsson, R., Moutsopoulos, H. M. et al., Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 2002, 61, 554-558.
4. Pijpe, J., Kalk, W. W. I., van der Wal, J. E., Vissink, A. et al., Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome. Rheumatology 2007, 46, 335-341.
5. Giusti, L., Baldini, C., Bazzichi, L., Bombardieri, S., Lucacchini, A., Proteomic diagnosis of Sjogren's syndrome. Expert Rev. Proteomics 2007, 4, 757-767.
6. Giusti, L., Baldini, C., Bazzichi, L., Ciregia, F. et al., Proteome analysis of whole saliva: a new tool for rheumatic diseases - the example of Sjögren's syndrome. Proteomics 2007, 7, 1634-1643.
7. Hu, S., Wang, J., Meijer, J., Ieong, S. et al., Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome. Arthritis Rheum. 2007, 56, 3588-3600.
8. Peluso, G., De Santis, M., Inzitari, R., Fanali, C. et al., Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum. 2007, 56, 2216-2222.
9. Ryu, O. H., Atkinson, J. C., Hoehn, G. T., Illei, G. G., Hart, T. C., Identification of parotid salivary biomarkers in Sjogren's syndrome by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional difference gel electrophoresis. Rheumatology 2006, 45, 1077-1086.
10. Baldini, C., Giusti, L., Bazzichi, L., Lucacchini, A., Bombardieri, S., Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome? Autoimmun. Rev. 2008, 7, 185-191.
11. Arbuckle, M. R., McClain, M. T., Rubertone, M. V., Scofield, R. H. et al., Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N. Engl. J. Med. 2003, 349, 1526-1533.
12. Franceschini, F., Cavazzana, I., Anti-Ro/SSA and La/SSB antibodies. Autoimmunity 2009, 38, 55-63.
13. Venables, P., Charles, P., Buchanan, R., Yi, T. et al., Quantitation and detection of isotypes of anti-SS-B antibodies by ELISA and Farr assays using affinity purified antigens. An approach to the investigation of Sjögren's syndrome and systemic lupus erythematosus. Arthritis Rheum. 1983 26, 146-155.
14. Goëb, V., Salle, V., Duhaut, P., Jouen, F. et al., Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome. Clin. Exp. Immunol. 2007, 148, 281-287.
15. Manoussakis, M. N., Georgopoulou, C., Zintzaras, E., Spyropoulou, M. et al., Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Arthritis Rheum. 2004, 50, 882-891.
16. Schnack, C., Danzer, K. M., Hengerer, B., Gillardon, F., Protein array analysis of oligomerization-induced changes in alpha-synuclein protein-protein interactions points to an interference with Cdc42 effector proteins. Neuroscience 2008, 154, 1450-1457.
17. Schnack, C., Hengerer, B., Gillardon, F., Identification of novel substrates for Cdk5 and new targets for Cdk5 inhibitors using high-density protein microarrays. Proteomics 2008, 8, 1980-1986.
18. Hu, S., Gao, K., Pollard, R., Arellano-Garcia, M. et al., Preclinical validation of salivary biomarkers for primary Sjögren's syndrome. Arthritis Care Res. 2010, 62, 1633-1638.
19. Chen, J. J., Wang, S. J., Tsai, C. A., Lin, C. J., Selection of differentially expressed genes in microarray data analysis. Pharmacogenomics J. 2006, 7, 212-220.
20. Predki, P. F., Mattoon, D., Bangham, R., Schweitzer, B., Michaud, G., Protein microarrays: a new tool for profiling antibody cross-reactivity. Hum. Antibodies 2005, 14, 7-15.
21. Mattoon, D., Michaud, G., Merkel, J., Schweitzer, B., Biomarker discovery using protein microarray technology platforms: antibody-antigen complex profiling. Expert Rev. Proteomics 2005, 2, 879-889.
22. Kang, S. W., Wahl, M. I., Chu, J., Kitaura, J. et al., PKC-beta modulates antigen receptor signaling via regulation of Btk membrane localization. EMBO J. 2001, 20, 5692-5702.
23. Hayashi, K., Altman, A., Protein kinase C theta (PKC theta): a key player in T cell life and death. Pharmacol. Res. 2007, 55, 537-544.
24. Hu, S., Zhou, M., Jiang, J., Wang, J. et al., Systems biology analysis of sjögren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands. Arthritis Rheum. 2009, 60, 81-92.
25. Davies, M. L., Taylor, E. J., Gordan, C., Young, S. P. et al., Candidate T cell epitopes of the human La/SSB autoantigen. Arthritis Rheum. 2002, 46, 209-214.
26. Luft, L. M., Barr, S. G., Martin, L. O., Chan, E. K. L., Fritzler, M. J., Autoantibodies to tissue transglutaminase in Sjogren's syndrome and related rheumatic diseases. J. Rheumatol. 2003, 30, 2613-2619.
27. Wei, F., Patel, P., Liao, W., Chaudhry, K. et al., Electrochemical sensor for multiplex biomarkers detection. Clin. Cancer Res. 2009, 15, 4446-4452.
28. Prabu, A., Marshall, T., Gordon, C., Plant, T. et al., Use of patient age and anti-Ro/La antibody status to determine the probability of patients with systemic lupus erythematosus and sicca symptoms fulfilling criteria for secondary Sjogren's syndrome. Rheumatology 2003, 42, 189-191.
29. Tan, H., Low, J., Lim, S., Chung, M., Serum autoantibodies as biomarkers for early cancer detection. FEBS J. 2009, 276, 6880-6904.
30. Kijanka, G., Murphy, D., Protein arrays as tools for serum autoantibody marker discovery in cancer. J. Proteomics 2009, 72, 936-944.
31. Raderer, M., Streubel, B., Woehrer, S., Puespoek, A. et al., High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin. Cancer Res. 2005, 11, 3349-3352.